CD99L2
CD99 antigen-like protein 2
Protein Summary
Plays a role in a late step of leukocyte extravasation helping cells to overcome the endothelial basement membrane. Acts at the same site as, but independently of, PECAM1 (By similarity). Homophilic adhesion molecule, but these interactions may not be required for cell aggregation (By similarity). This gene encodes a cell-surface protein that is similar to CD99. A similar protein in mouse functions as an adhesion molecule during leukocyte extravasation. Alternate splicing results in multiple transcript variants. [provided by RefSeq, May 2010]
- ENST00000346693
- ENSP00000489222
- ENSG00000102181
- ENST00000355149
- ENSP00000347275
- ENST00000370377
- ENSP00000359403
- ENST00000437787
- ENSP00000394858
- ENST00000466436
- ENSP00000417697
- ENST00000613030
- ENSP00000480322
- MIC2L1
- CD99B
- MIC2L1
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
|---|---|---|---|
histone modification site profile | 0.88 | ||
disease perturbation | 0.87 | ||
transcription factor perturbation | 0.74 | ||
kinase perturbation | 0.71 | ||
cellular component | 0.61 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 13.19 (req: < 5)
Gene RIFs: 3 (req: <= 3)
Antibodies: 148 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 13.19 (req: >= 5)
Gene RIFs: 3 (req: > 3)
Antibodies: 148 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 4
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligand: 0
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0